April 4, 2025 05:10 PM EDTUpdated 3 hours ago

Trump administration leaves obesity coverage expansion out of new Medicare rule

Nicole DeFeudis

Editor

The Trump administration finalized new policies for some Medicare programs on Friday, but left out provisions that would have expanded coverage of anti-obesity drugs to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Trump administration leaves obesity coverage expansion out of new Medicare rule

Nicole DeFeudis

Editor

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

Secretive Chinese startup begins first-ever clinical trial of circular RNA therapy

Marks was asked to provide non-existent vaccine risk data: WSJ

Novavax’s held-up approval package may signal warning for Covid vaccine makers

Kennedy team defends Marks firing, while 20% of staff cuts may be 'mistakes'

China's retaliatory tariffs on US could mean more headwinds for drugmakers

Endpoints webinar: Inside the “One Lonza” strategy: Re-engineering the future of CDMO

Trump ad­min­is­tra­tion leaves obe­si­ty cov­er­age ex­pan­sion out of new Medicare rule

Editor

Sign up to read this article for free.

ImmunityBio, Inc.

Remote

Trump administration leaves obesity coverage expansion out of new Medicare rule